Randomized trial of doripenem or meropenem in the treatment of febrile neutropenia
Not Applicable
- Conditions
- patients with febrile neutropenia
- Registration Number
- JPRN-UMIN000006944
- Lead Sponsor
- Tokyo Women's Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
allergic to carbapenem LC pregnant woman
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method effectiveness at 7days after the start of treatment
- Secondary Outcome Measures
Name Time Method effectiveness at 3 and 5 days after the start of treatment